[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-444106-105":59,"doc-detail-444106-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","retracted-potential-antitumor-activity-of-combined-lycopene-and-sorafenib-against-solid-ehrlich-carcinoma-retraction-notice","RETRACTED - Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma - Retraction Notice","","Retraction notice for the paper “Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation” in Pharmaceuticals (2024, 17, 527). The journal reports concerns about the integrity of multiple images after publication and an editorial investigation identifying irregularities and partial duplication in Figures 2–4. The authors collaborated but could not provide full original raw materials for evaluation, leading the journal to retract the article under its retraction policy; the editor-in-chief approved the retraction and the authors disagreed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/retracted-potential-antitumor-activity-of-combined-lycopene-and-sorafenib-against-solid-ehrlich-carcinoma-retraction-notice/444106/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/retracted-potential-antitumor-activity-of-combined-lycopene-and-sorafenib-against-solid-ehrlich-carcinoma-retraction-notice/444106.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-09-30","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was the article retracted?","Question",{"text":112,"@type":113},"Concerns were raised about the integrity of images in the publication. The editorial investigation identified irregularities and partial duplication in Figures 2–4.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence could not be provided during evaluation?",{"text":117,"@type":113},"The authors could not provide the full raw original materials required by the journal for evaluation by the editorial board.",{"name":119,"@type":110,"acceptedAnswer":120},"Did the authors agree with the retraction?",{"text":121,"@type":113},"No. The retraction was approved by the journal’s Editor-in-Chief, but the authors disagreed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},444106,1790765243,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":81},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Retraction  \nRETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527  \nThanaa A. El-Masry 1, *,†, Maysa M. F. El-Nagar 1, *,†, Nageh A. El Mahdy 1, Fatemah A. Alherz 2, Reham Taher 1 and Enass Y. Osman 1  \nReceived: 4 December 2025  \nAccepted: 23 December 2025  \nPublished: 29 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt  \n2 Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia  \n* Correspondence: [thanaa.elmasri@pharm.tanta.edu.eg](thanaa.elmasri@pharm.tanta.edu.eg) (T.A.E.-M.); [maysa_elnagar@outlook.com](maysa_elnagar@outlook.com) (M.M.F.E.-N.)† These authors contributed equally to this work.  \nThe journal retracts the article “Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation” [1] cited above.  \nFollowing publication, concerns were brought to the attention of the Editorial Office regarding the integrity of a number of images presented in this publication [1] .  \nAdhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified irregularities and partial duplication in Figures 2–4 presented in this article. While the authors collaborated with this process, full raw material meeting the journal’s requirements for original images ([https://www.mdpi.com/](https://www.mdpi.com/)[ ](https://www.mdpi.com/)[journal/pharmaceuticals/instructions\\#oriimages](journal/pharmaceuticals/instructions#oriimages), [accessed on 3 December 2025](accessed on 3 December 2025)) [could not](could not)[ ](could not)be provided for evaluation by the Editorial Board. Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy ([https://www.mdpi.com/ethics\\#_bookmark30](https://www.mdpi.com/ethics#_bookmark30), accessed on 3 December 2025) .  \nThis retraction was approved by the Editor-in-Chief of the journal Pharmaceuticals. The authors disagreed to this retraction.  \nReference  \n1. El-Masry, T.A.; El-Nagar, M.M.F.; El Mahdy, N.A.; Alherz, F.A.; Taher, R.; Osman, E.Y. RETRACTED: Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527 . [CrossRef] [PubMed]  \nDisclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s) . MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.","cbCaie1zix3wNTdL","https://ap.wps.com/l/cbCaie1zix3wNTdL","pdf",135323,"English","# Retraction scope\n## Editorial concerns and investigation\n## Decision and approval\n## Author response\n## Reference","[{\"question\":\"Why was the article retracted?\",\"answer\":\"Concerns were raised about the integrity of images in the publication. The editorial investigation identified irregularities and partial duplication in Figures 2–4.\"},{\"question\":\"What evidence could not be provided during evaluation?\",\"answer\":\"The authors could not provide the full raw original materials required by the journal for evaluation by the editorial board.\"},{\"question\":\"Did the authors agree with the retraction?\",\"answer\":\"No. The retraction was approved by the journal’s Editor-in-Chief, but the authors disagreed.\"}]","RETRACTED - Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma - Retraction Notice | PDF",1790706897]